Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair

Completed · Not applicable · Has a placebo group

Conditions studied: PAD, Abdominal Aortic Aneurysm

In brief

The purpose of this study is to determine if high-dose PUFA supplementation in patients undergoing EVAR for infra-renal AAA reduces the peri-operative inflammation.

Key facts

Study ID

NCT03208920

Run by

University of California, San Francisco

People needed

2

Starts

2016-12-01

Expected to finish

2018-08-28

Last updated by the study team

2021-07-14

Who can join

Age: 40 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Undergoing EVAR for infra-renal AAA and/or iliac artery aneurysm

You may not qualify if…

• Age < 40 or > 90 years
• On dual antiplatelet therapy or anticoagulation
• Evidence of active infection
• Diagnosed hypercoagulable state
• Non-atherosclerotic/aneurysmal disease as indication for procedure
• Chronic liver disease or myopathy
• End-stage renal disease (CKD 5)
• Poorly controlled diabetes (HbA1C > 8%)
• Recent other major surgery or illness within 6 weeks
• Use of immunosuppressive medication or extant chronic inflammatory disorders
• History of organ transplantation
• Pregnancy or plans to become pregnant
• Condition in which patient life expectancy is less than one year
• Known allergy to fish or fish products
• Presence of symptomatic or ruptured AAA

Where it is running

• San Francisco Veteran Affairs Medical Center — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.